The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year.
Johnson & Johnson’s TREMFYA gains FDA approval
With the new approval, Johnson and Johnson’s TREMFYA now has three indications. Credit: Skorzewiak/Shutterstock. Johnson & Johnson has announced that the US Food and Drug